A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
This study investigates safety and efficacy of CP-690,550 in adult patients with moderate to severe Crohn's disease. The study hypothesis is that at least one dose of the tested drug is more effective than placebo (inactive drug).
Inclusion Criteria:
Exclusion Criteria:
Crystal River, Florida 34429, United States
Milwaukee, Wisconsin 53215, United States
Montreal, Quebec H3G1A4, Canada
Kolonaki Athens, 106 76, Greece
Budapest, 1076, Hungary
Budapest, 1125, Hungary
Bunkyo-ku, Tokyo 1138519, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Donetsk, 83017, Ukraine
Lviv, 79010, Ukraine
Odesa, 65117, Ukraine